Agrandamiento gingival por vigabatrina. Descripción clínica e histopatológica de un nuevo caso

  1. Mesa Aguado, FL
  2. López Leyva, C
  3. González Moles, MA
  4. Moral, RG del
  5. O'valle Ravassa, FJ
Zeitschrift:
Medicina oral

ISSN: 1137-2834

Datum der Publikation: 2000

Ausgabe: 5

Nummer: 2

Seiten: 133-137

Art: Artikel

Andere Publikationen in: Medicina oral

Zusammenfassung

Gamma-vinyl GABA (vigabatrin, VGB) is a relatively recent drug prescribed to adolescents and adults with epileptic seizures refractory to conventional treatment. No type of oral disorder is mentioned among its adverse effects. However, a 29-year-old male treated during 5 years with VGB for partial epileptic seizures refractory to classic anticonvulsive treatment presented a moderate overgrowth of the free and attached gingiva. The present case is the first described in Spain, and the second in the world literature. We provide a clinical, histopathological and morphometric description of the gingival lesion. These data should be of value to the clinician for counseling patients on risks and for minimizing symptoms.